Table 2.
Tumour sample 1 | Spores analysed | LRI1 (F type) 2 (m1) | LRII1 (W type) 2 (m2) | ||||||
---|---|---|---|---|---|---|---|---|---|
a | b | c | d | a | b | c | d | ||
Δatg11#1 | 8 | 0 | 0 | 0 | 6 | 8 | 0 | 0 | 0 |
Δatg11#2 | 10 | 0 | 0 | 0 | 5 | 10 | 0 | 0 | 0 |
Δatg11#3 | 21 | 0 | 0 | 0 | 8 | 21 | 0 | 0 | 0 |
Δatg11#4 | 10 | 0 | 0 | 0 | 6 | 10 | 0 | 0 | 0 |
Δatg11#5 | 9 | 0 | 0 | 0 | 1 | 9 | 0 | 0 | 0 |
Δatg11#6 | 11 | 0 | 0 | 0 | 3 | 11 | 0 | 0 | 0 |
Δatg11#7 | 11 | 0 | 0 | 0 | 3 | 11 | 0 | 0 | 0 |
Δatg11#8 | 11 | 0 | 0 | 0 | 2 | 11 | 0 | 0 | 0 |
Δatg11#9 | 11 | 0 | 0 | 0 | 1 | 11 | 0 | 0 | 0 |
Δatg11#10 | 10 | 0 | 0 | 0 | 1 | 10 | 0 | 0 | 0 |
Δatg11#11 | 11 | 0 | 0 | 0 | 3 | 11 | 0 | 0 | 0 |
Σ | 123 | 0 | 0 | 0 | 39 (31.7) 3 | 123 | 0 | 0 | 0 |
wt #12 | 10 | 0 | 0 | 0 | 5 | 10 | 0 | 0 | 0 |
wt #13 | 10 | 0 | 0 | 0 | 2 | 10 | 0 | 0 | 0 |
wt #14 | 10 | 0 | 0 | 0 | 1 | 10 | 0 | 0 | 0 |
wt #15 | 9 | 0 | 0 | 0 | 2 | 9 | 0 | 0 | 0 |
wt #16 | 8 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 |
wt #17 | 11 | 0 | 0 | 0 | 3 | 11 | 0 | 0 | 0 |
wt #18 | 11 | 0 | 0 | 0 | 5 | 11 | 0 | 0 | 0 |
wt #19 | 11 | 0 | 0 | 0 | 3 | 11 | 0 | 0 | 0 |
wt #20 | 11 | 0 | 0 | 0 | 3 | 11 | 0 | 0 | 0 |
wt #21 | 11 | 0 | 0 | 0 | 5 | 11 | 0 | 0 | 0 |
wt #22 | 9 | 0 | 0 | 0 | 1 | 9 | 0 | 0 | 0 |
wt #23 | 11 | 0 | 0 | 0 | 2 | 11 | 0 | 0 | 0 |
Σ | 122 | 0 | 0 | 0 | 32 (26.2) 3 | 122 | 0 | 0 | 0 |
1Wt strain combination: FB1/pMB2-2 x GF5/pKS1; Δatg11 strain combination: FB1Δatg11/pMB2-2 × GF5Δatg11/pKS1.
2Relative percentages of band intensities are indicated as: a) >97%, b) >50-97%, c) 3-50%, d) <3%.
3Values expressed in percentages (%).